Skip to Content

SOC Telemed, Inc.

Merger

  • Date:
  • 2/3/2022
  • Company Name:
  • SOC Telemed, Inc.
  • Stock Symbol:
  • TLMD
  • Company Name - Buyer:
  • Patient Square Capital
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 2/3/2022

Case Finder

Locate any case using the tools below.

NEW YORK, February 3, 2022 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of SOC Telemed, Inc. (NASDAQ: TLMD) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Patient Square Capital.

On February 3, 2022, SOC Telemed announced that it had entered into an agreement to be acquired by Patient Square in an all-cash transaction.  Pursuant to the merger agreement, SOC Telemed stockholders will receive $3 in cash for each share of SOC Telemed common stock owned.  The deal is scheduled to close in the second quarter of 2022.

Bragar Eagel & Squire is concerned that SOC Telemed’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.  Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for SOC Telemed’s stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in SOC Telemed. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: